In the first aspect, the metabolic activity of HK2, as a glucokinase, could play a vital role in immune escape and resistance to radio/chemotherapy (cisplatin, paclitaxel) during tumorigenesis and tumor development [10, 38]. This evidence concerns the gene GCK and neoplasm.